FIELD: pharmaceuticals.
SUBSTANCE: invention relates to polymorph of N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide (compound of formula I) in form of mesylate salt, selected from a group consisting of crystalline form I–VI of mesylate salt, wherein said crystalline forms are characterized by X-ray powder diffraction patterns such as given in the claim. Invention also relates to a method of producing crystalline forms of I–VI mesylate salt of a compound of formula I and use thereof.
EFFECT: technical result is crystalline forms of I–VI mesylate salt N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide, having improved physical and chemical properties, such as degree of crystallinity, solubility, hygroscopicity and chemical stability, and suitable for preparing a drug for treating a disease mediated by EGFR mutant activity or a deletion-activated mutant in exon 19.
12 cl, 22 tbl, 22 ex, 22 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| POLYMORPHOUS AND AMORPHOUS FORMS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINE[5,4,3-CD]INDOL-6-ON PHOSPHATE | 2005 |
|
RU2355691C2 |
| AMINE SOLVATE OF SODIUM GLUCOSE OPENER OF SODIUM GLUCOSE OPENER AND METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2710230C1 |
| LONG-ACTING DPP-IV INHIBITOR CRYSTAL AND ITS SALTS | 2017 |
|
RU2753335C2 |
| CRYSTALLINE FORM OF COMPOUND SUPPRESSING PROTEIN KINASE ACTIVITY AND THE USE THEREOF | 2017 |
|
RU2744264C2 |
| POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
| QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR | 2014 |
|
RU2656597C2 |
| POLYMORPHOUS FORMS OF ICOTINIB MALEATE AND USES THEREOF | 2014 |
|
RU2708079C2 |
| DIARYLTHIOHYDANTOIN COMPOUND CRYSTAL | 2020 |
|
RU2810214C2 |
| NOVEL POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF | 2014 |
|
RU2712169C2 |
| SALT AND POLYMORPH OF A PHENYL-PYRIMIDONE COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2018 |
|
RU2761213C2 |
